A European multi-center trial investigating the anti-restenotic effect of intravascular sonotherapy after stenting de novo lesions (EUROSPAH: EUROpean Sonotherapy Prevention of Arterial Hyperplasia)

International Journal of Cardiovascular Interventions

Volumn 6, Issue 2, 2004, Pages 53-60

  Serruys, P W ^a   Hoye, A ^a   Grollier, G ^b   Colombo, A ^c   Symons, J ^d   Mudra, H ^e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CHU CÔTE DE NACRE   (France)

^c EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^d CARDIALYSIS   (Netherlands)

^e Krankenhaus Neuperlach   (Germany)

Author keywords

Angioplasty; Restenosis; Sonotherapy; Stent

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ANGIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DEVICE; DOUBLE BLIND PROCEDURE; EUROPE; FEMALE; FOLLOW UP; HUMAN; INTRAVASCULAR SONOTHERAPY; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SILENT MYOCARDIAL ISCHEMIA; SURVIVAL; TREATMENT OUTCOME;

AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; REOPERATION; STENTS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 4644357259     PISSN: 14628848     EISSN: None     Source Type: Journal    
DOI: 10.1080/14628840410030405     Document Type: Article

References (20)

1. Serruys PW, Sianos G, van der Giessen W et al. Intracoronary beta-radiation to reduce restenosis after balloon angioplasty and stenting; the Beta Radiation In Europe (BRIE) study. Eur Heart J 2002; 23: 1351-9.
2. Regar E, Kozuma K, Sianos G et al. Routine intracoronary beta-irradiation. Acute and one year outcome in patients at high risk for recurrence of stenosis. Eur Heart J 2002; 23: 1038-44.
3. Degertekin M, Serruys PW, Foley DP et al. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation 2002; 106: 1610-3.
4. Morice MC, Serruys PW, Sousa JE et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-80.
5. Lemos PA, Serruys PW, van Domburg RT, Saia F et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world." The Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 2004; 109: 190-5.
6. Popma JJ, Topol EJ. Factors influencing restenosis after coronary angioplasty. Am J Med 1990; 88: 16N-24N.
7. Doan N, Reher P, Meghji S et al. In vitro effects of therapeutic ultrasound on cell proliferation, protein synthesis, and cytokine production by human fibroblasts, osteoblasts, and monocytes. J Oral Maxillofac Surg 1999; 57: 409-19, 420.
8. Asahara T, Bauters C, Pastore C et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 1995; 91: 2793-801.
9. Asahara T, Chen D, Tsurumi Y et al. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation 1996; 94: 3291-302.
10. Alter A, Rozenszajn LA, Miller HI et al. Ultrasound inhibits the adhesion and migration of smooth muscle cells in vitro. Ultrasound Med Biol 1998; 24: 711-21.
11. Lawrie A, Brisken AF, Francis SE et al. Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. Circulation 1999; 99: 2617-20.
12. Fitzgerald PJ, Takagi A, Moore MP et al. Intravascular sonotherapy decreases neointimal hyperplasia after stent implantation in swine. Circulation 2001; 103: 1828-31.
13. Regar E, Thury A, van der Giessen WJ et al. Sonotherapy, antirestenotic therapeutic ultrasound in coronary arteries: the first clinical experience. Catheter Cardiovasc Interv 2003; 60: 9-17.
14. Gibbons RJ, Abrams J, Chatterjee K et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003; 107: 149-58.
15. Braunwald E. Unstable angina. A classification. Circulation 1989; 80: 410-4.
16. Serruys PW, Degertekin M, Tanabe K et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 2002; 106: 798-803.
17. Blackburn H. Electrocardiographic classification for population comparisons. The Minnesota code. J Electrocardiol 1969; 2: 5-9.
18. Serruys PW, van Hout B, Bonnier H et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998; 352: 673-81.
19. Kim HS, Waksman R, Cottin Y et al. Edge stenosis and geographical miss following intracoronary gamma radiation therapy for in-stent restenosis. J Am Coll Cardiol 2001; 37: 1026-30.
20. Sianos G, Kay IP, Costa MA et al. Geographical miss during catheter-based intracoronary beta-radiation: incidence and implications in the BRIE study. Beta-Radiation In Europe. J Am Coll Cardiol 2001; 38: 415-20.